1. Home
  2. EBAY vs ONC Comparison

EBAY vs ONC Comparison

Compare EBAY & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eBay Inc.

EBAY

eBay Inc.

HOLD

Current Price

$95.92

Market Cap

37.4B

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$303.17

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBAY
ONC
Founded
1995
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.4B
31.4B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
EBAY
ONC
Price
$95.92
$303.17
Analyst Decision
Buy
Strong Buy
Analyst Count
28
12
Target Price
$97.23
$374.75
AVG Volume (30 Days)
4.2M
182.1K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.27%
N/A
EPS Growth
10.15
N/A
EPS
4.34
N/A
Revenue
$17,902,000,000.00
N/A
Revenue This Year
$10.44
$747.23
Revenue Next Year
$5.06
$15.78
P/E Ratio
$22.50
$614.06
Revenue Growth
11.56
N/A
52 Week Low
$58.97
$196.53
52 Week High
$101.15
$385.22

Technical Indicators

Market Signals
Indicator
EBAY
ONC
Relative Strength Index (RSI) 63.28 52.14
Support Level $87.29 $295.97
Resistance Level $97.97 $311.10
Average True Range (ATR) 2.72 7.59
MACD 0.69 4.85
Stochastic Oscillator 81.63 71.79

Price Performance

Historical Comparison
EBAY
ONC

About EBAY eBay Inc.

EBay operates one of the largest e-commerce marketplaces in the world, with $75 billion in 2024 gross merchandise volume, rendering the firm a top 10 global e-commerce company. It generates sales from listing fees, advertising, revenue-sharing arrangements with service providers, and managed payments, with its platform connecting more than 130 million buyers and roughly 20 million sellers across almost 190 global markets at the end of 2024. EBay generates just north of 50% of its GMV in international markets, with a large presence in the UK, Germany, and Australia.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: